Alexandria Real Estate Equities
CFO | |
Revenue | $2.588 billion (2022) |
---|---|
$513 million (2022) | |
Total assets | $35.523 billion (2022) |
Total equity | $18.972 billion (2022) |
Number of employees | 593 (2022) |
Website | www |
Footnotes / references [1] |
Alexandria Real Estate Equities, Inc. is a
The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms.[2]
The company is named after Alexandria, Egypt because of that city's connection to science.[3]
Investments
As of December 31, 2022, the company owned or had investments in 41.7 million square feet of operating properties in addition to properties under construction.[1]
The company's largest tenants are as follows:[1]
Rank | Tenant | % of 2022 Revenue |
---|---|---|
1 | Bristol-Myers Squibb
|
3.5% |
2 | Moderna | 2.6% |
3 | Eli Lilly and Company | 2.5% |
4 | Takeda Pharmaceutical Company | 1.9% |
5 | Illumina, Inc. | 1.8% |
6 | Sanofi | 1.7% |
7 | 2seventy bio | 1.7% |
8 | Novartis | 1.5% |
9 | TIBCO Software | 1.4% |
10 | Uber | 1.4% |
The company's revenues are derived in the following markets:
Rank | Location | % of 2022 Revenue |
---|---|---|
1 | Greater Boston | 36% |
2 | San Francisco Bay Area | 23% |
3 | San Diego | 16% |
4 | Maryland | 6% |
5 | New York City | 5% |
6 | Seattle | 5% |
7 | Research Triangle, North Carolina | 5% |
8 | Texas | 2% |
9 | Canada | 1% |
10 | Other | 1% |
Properties are generally located near universities to attract tenants.[4] The company has several properties in Kendall Square in Cambridge, Massachusetts, where it has invested over $2.3 billion since its first investment in the neighborhood in 2002.[5] Its largest campuses in Boston are the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square (Cambridge, Massachusetts).[1]
The company's 740,972 square foot Alexandria Center for Life Science in Manhattan has several biotechnology tenants.[6][1]
The company's San Diego properties are primarily in Torrey Pines, San Diego, University City, San Diego, and Sorrento Mesa, San Diego.[1]
History
In 1993, one of the partners of
Its first purchase was of 4 buildings in San Diego which had been negotiated and structured by Kendell R. Lang.[4]
In 1997, it became a public company via an initial public offering, raising $155 million.[4]
In October 2002, the company acquired the headquarters of ZymoGenetics for $52 million in a leaseback transaction.[8]
In 2007, the company began the development of the West Tower of the
In January 2013, the company sold a research facility in Seattle to Trammell Crow Company for $42.6 million.[11]
In June 2018, the company acquired an office building leased to
In July 2018, the company acquired 219 East 42nd Street, the headquarters of Pfizer, for $203 million in a leaseback transaction.[13]
References
- ^ a b c d e f g "Alexandria Real Estate Equities, Inc. 2022 Form 10-K Annual Report". U.S. Securities and Exchange Commission.
- ^ Fidler, Ben (June 8, 2016). "Alexandria Sets up Incubator, $25M Seed Fund For NY Bio Startups". Xconomy.
- ^ Alcorn, Stacey (January 25, 2016). "Alexandria Real Estate Equities: More Than Just a Landlord". HuffPost.
- ^ a b c Hartung, Adam (May 20, 2017). "The #1 Real Estate Stock To Own Is Built On Trends". Forbes.
- ^ Ross, Carey (April 14, 2015). "A real estate empire grows in Kendall Square". The Boston Globe.
- ^ Ramsey, Lydia; Johnson, Hollis (July 14, 2016). "Take a look inside the stunning offices where companies are reinventing NYC's biotech scene". Business Insider.
- ^ Derven, Ron (Fall 2019). "Alexandria Real Estate Equities, Inc.: People, Passion, Purpose". NAIOP.
- ^ "ZymoGenetics sells headquarters in $52 million lease-back deal". American City Business Journals. October 7, 2002.
- ^ "MaRS selects Alexandria Real Estate Equities to expand the MaRS Centre in the Discovery District of Toronto". MaRS Discovery District. June 26, 2007.
- ^ Benzie, Robert (September 23, 2014). "Ontario government bails out MaRS building for $309m". Toronto Star.
- ^ Stiles, Marc (January 23, 2013). "Trammell Crow Co. back in the game in Seattle with $42.6 million acquisition". American City Business Journals.
- ^ Stiles, Marc (June 7, 2018). "Another Amazon-leased building sells for $95 million". American City Business Journals.
- ^ "Alexandria Real Estate Equities, Inc. Expands Its First-in-Class New York City Regional Life Science Cluster Franchise with the Strategic Acquisition of 219 East 42nd Street in Manhattan, Subject to a Leaseback" (Press release). PR Newswire. July 13, 2018.
External links
- Official website
- Business data for Alexandria Real Estate Equities, Inc.: